(Note: Aveanna Healthcare priced its downsized IPO at $12 – the low end of its sharply lowered range of $12 to $13 – on 38.24 million shares – the same number of shares as in the prospectus – to raise $458.88 million. Aveanna had cut its price range to $12 to $13 – down from $16 to $18 initially – on the same number of shares – 38.24 million – to raise $478 million, if priced at the mid-point, in an S-1/A filing dated April 28, 2021. The IPO is now scheduled for pricing Wednesday night, April 28, to start trading on Thursday, April 29 – a delay of one day from the original schedule.)

We are a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations. We directly address the most pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home, the lower cost care setting preferred by patients. Our patient-centered care delivery platform is designed to improve the quality of care our patients receive, which allows them to remain in their homes and minimizes the overutilization of high-cost care settings such as hospitals. Our clinical model is led by our caregivers, primarily skilled nurses, who provide specialized care to address the complex needs of each patient we serve across the full range of patient populations: newborns, children, adults and seniors. 

Over the past five years, we have scaled our business by a factor of approximately 5x, expanding from 17 states and $324.6 million of revenue in 2016 to 30 states and $1.5 billion in revenue in fiscal year 2020. We currently have 245 branch locations. We have recently expanded into adult home health and hospice for Medicare populations, adding a new platform to help drive our future growth. 

(Note: Revenue and net loss figures are for the fiscal year that ended Jan. 2, 2021.)